{"text": ["Cancer", "Space", "Update:", "Label", "Expansions,", "Data", "Readouts", "in", "Focus"], "created_at": "2018-01-19 18:00:23"}
{"text": ["Notable", "ETF", "Inflow", "Detected", "-", "VEA,", "NSRGY,", "NVS,", "TM"], "created_at": "2018-01-19 17:00:08"}
{"text": ["Cancer", "Space", "Update:", "Label", "Expansions,", "Data", "Readouts", "in", "Focus"], "created_at": "2018-01-19 15:23:03"}
{"text": ["Pharma", "Stock", "Roundup:", "Merck's", "Keytruda", "Shines", "in", "Study,", "Priority", "Review", "for", "Kymriah", "Label", "Expansion"], "created_at": "2018-01-19 13:01:05"}
{"text": ["How", "Is", "Bristol-Myers", "Squibb\u2019s", "Sprycel", "Positioned", "for", "2018?"], "created_at": "2018-01-19 12:33:12"}
{"text": ["Amgen\u2019s", "Aimovig", "is", "Expected", "to", "Witness", "Steady", "Growth", "in", "2018"], "created_at": "2018-01-19 12:30:57"}
{"text": ["The", "Swiss", "Stock", "Market", "Climbed", "Again,", "But", "Finishes", "Week", "With", "A", "Loss"], "created_at": "2018-01-19 12:21:00"}
{"text": ["Blog", "Exposure", "-", "FDA", "Granted", "Priority", "Review", "to", "Novartis\u2019", "Kymriah(TM)", "for", "Adults", "with", "relapsed/refractory", "B-cell", "lymphoma"], "created_at": "2018-01-19 12:00:00"}
{"text": ["Pharma", "Stock", "Roundup:", "Merck&apos;s", "Keytruda", "Shines", "in", "Study,", "Priority", "Review", "for", "Kymriah", "Label", "Expansion"], "created_at": "2018-01-19 10:55:10"}
